# Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/obinutuzumab-for-the-first-line-treatment-of-follicular-lymphoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert Marcus,Andrew Davies,Kiyoshi Ando,Wolfram Klapper,Stephen Opat,Carolyn Owen,Elizabeth H. Phillips,Randeep Sangha,Rudolf Schlag,John F. Seymour,William Townsend,Marek Trněný,Michael Wenger,Günter Fingerle‐Rowson,Kaspar Rufibach,Tom Moore,Michael Herold,Wolfgang Hiddemann |
| Citations | 795 |
| DOI | 10.1056/nejmoa1614598 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1614598?articleTools=true |
| OpenAlex ID | https://openalex.org/W2761878534 |
| PMID | 28976863 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Kiyoshi Ando](https://scholariq.org/researchers/kiyoshi-ando/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.